This announcement is a separate document:
北京市嘉源律师事务所关于科兴生物制药股份有限公司2022年限制性股票激励计划首次授予部分第二个归属期及预留授予部分第一个归属期归属条件成就及部分限制性股票作废事项的法律意见书
Legal Opinion from Jiayuan Law Firm, Peking, regarding Sinovac Biotech Limited's 2022 Restricted Stock Incentive Plan - First Grant of the Second Vesting Period and Achievement of Vesting Conditions and Invalidation of Part of the Restricted Stock.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.